Drug recall · October 24, 2018
Premier Value recall
Why: CGMP Deviations: products manufactured under conditions that could impact its product quality.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Premier Value, Nasal Decongestant, Nasal Spray (oxymetazoline HCl 0.05%), Regular Strength, 1 FL OZ (30 mL) bottle, Distributed By Chain Drug Consortium, 3301 NW Boca Raton Blvd, Suite 101, Boca Raton, FL 33431, NDC 68016-316-03, UPC 8 40986 01516 8.
- Lots / codes
All lots remaining within expiry.
- Quantity
- 4992 bottles
- Company
- Product Quest Manufacturing LLC, Daytona Beach, FL
- Distribution
- Nationwide in the USA
- Initiated
- August 3, 2018 · Voluntary: Firm initiated
- Classified
- October 16, 2018
- Reported
- October 24, 2018
- Ended
- March 30, 2021
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Recalled with it (same recall event)
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Oxymetazoline
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.